Showing results (71-80 of 319) with videos related to

Sort By:
Pageof 32
Plos One|June 20, 2020
Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitorSu-Lin Lim, Liang Xu, Bing-Chen Han, et al.
NPJ Precision Oncology|December 10, 2019
Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochipBee Luan Khoo, Menglin Shang, Chin Hin Ng, et al.
Nanomedicine (London, England)|December 4, 2013
Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemiaKuan-Boone Tan, Leong-Uung Ling, Ralph M Bunte, et al.
British Journal of Haematology|January 17, 2014
CD137 ligand signalling induces differentiation of primary acute myeloid leukaemia cellsKin Cheng, Siew Cheng Wong, Yeh Ching Linn, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 6, 2020
Bacterial Infection Among Patients With Multiple Myeloma Treated With Bortezomib-based Induction Therapy: Real-World Experience in an Asian Cancer CenterCinnie Yentia Soekojo, Jia Zhen Low, Jaslyn Oh, et al.
Cell Death Discovery|May 8, 2021
The oncogenic E3 ligase TRIP12 suppresses epithelial-mesenchymal transition (EMT) and mesenchymal traits through ZEB1/2Kwok Kin Lee, Deepa Rajagopalan, Shreshtha Sailesh Bhatia, et al.
Cancer Genetics and Cytogenetics|June 15, 2004
Translocation (8;22) in cold agglutinin disease associated with B-cell lymphomaWee Joo Chng, Jean Chen, Susan Lim, et al.
Biotechnology Letters|October 1, 2010
Therapeutic potential of antisense oligodeoxynucleotides in downregulating p53 oncogenic mutations in cancersZhigang Xie, Wee Joo Chng, Kian Ghee Tay, et al.
Haematologica|August 16, 2019
IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplificationPhaik Ju Teoh, Tae-Hoon Chung, Pamela Y Z Chng, et al.
Cancers|July 8, 2020
Immunoglobulin M ParaproteinaemiasLouis-Pierre Girard, Cinnie Yentia Soekojo, Melissa Ooi, et al.
Pageof 32